Skip to main content
Loading

Sarcomatrix Therapeutics Corp

October 17, 2023
Franciscan B
Infectious Diseases
Sarcomatrix is a preclinical stage biopharma developing novel therapeutics and enabling technologies across multiple indications; starting with muscle wasting diseases and muscular dystrophies.
Speakers
David Craig, President and CEO - Sarcomatrix Therapeutics Corp

Company Type

Privately Funded

Website

http://www.sarcomatrix.com

CEO/Top Company Official

David Craig, MBA

Lead Product in Development

S-969 oral small molecule potent α7β1 integrin enhancer that promotes muscle regeneration in all muscle types by stimulating satellite cells.

Number Of Unlicensed Products

Two

BIO DOUBLE HELIX SPONSOR

BIO HELIX SPONSOR

CONFERENCE SPONSORS